ACADIA Pharmaceuticals
ACAD
$15.28
Share price
0.46%
Change (1 day)
-28.70%
Change (1 year)
Categories
ACADIA Pharmaceuticals (ACAD) - Total assets
Total assets on the balance sheet as of December 2023 : $0.74 B
According to ACADIA Pharmaceuticals's latest financial reports the company's total assets are $0.74 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
ACADIA Pharmaceuticals - Total assets on balance sheet (from 2003 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.74 B | 27.41% |
| 2022-12-31 | $0.58 B | -16.04% |
| 2021-12-31 | $0.70 B | -10.54% |
| 2020-12-31 | $0.78 B | -0.07% |
| 2019-12-31 | $0.78 B | 44.98% |
| 2018-12-31 | $0.54 B | 40.49% |
| 2017-12-31 | $0.38 B | -31.48% |
| 2016-12-31 | $0.56 B | 152.89% |
| 2015-12-31 | $0.22 B | -31.82% |
| 2014-12-31 | $0.32 B | 72.09% |
| 2013-12-31 | $0.18 B | 74.16% |
| 2012-12-31 | $0.10 B | 238.14% |
| 2011-12-31 | $32.11 M | -16.36% |
| 2010-12-31 | $38.39 M | -22.72% |
| 2009-12-31 | $49.68 M | -23.19% |
| 2008-12-31 | $64.67 M | -51.94% |
| 2007-12-31 | $0.13 B | 50.3% |
| 2006-12-31 | $89.54 M | 43.26% |
| 2005-12-31 | $62.5 M | 54.85% |
| 2004-12-31 | $40.36 M | 27.36% |
| 2003-12-31 | $31.69 M | 97.79% |
| 2002-12-31 | $16.02 M | -27.03% |
| 2001-12-31 | $21.95 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 22,860.76% | 🇺🇸 USA |
 Pfizer PFE | $226.50 B | 30,142.23% | 🇺🇸 USA |
 Eli Lilly LLY | $63.94 B | 8,437.68% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 13,122.54% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $0.64 B | -13.42% | 🇺🇸 USA |
 Adamas Pharmaceuticals
ADMS | N/A | N/A | 🇺🇸 USA |